Mammalian Cell Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Mammalian Cell Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global Mammalian Cell Banking Market, which was valued at approximately US$ 484 Million in 2024, is projected to experience a remarkable surge, with an anticipated Compound Annual Growth Rate (CAGR) of 16%. By the end of 2033, the market is expected to reach a staggering valuation of around US$ 1400 million, according to the latest market outlook report.

Mammalian cells, derived from mammalian tissues, play a pivotal role in various biotechnology applications, including the production of viruses, proteins, and modeling of biological systems and diseases. The increasing focus on oncological research, coupled with substantial investments from institutions like the National Cancer Institute, is driving the growth of the Mammalian Cell Banking Market.

Increasing Focus on Oncological Research to Boost Market Growth

Cancer research is at the forefront of driving growth in the Mammalian Cell Banking Market. The unique receptivity of cancer cells to in vitro culture has made mammalian cell culture a cornerstone in oncology research. Cell lines offer a continuous supply of biological material crucial for scientific experiments. Furthermore, government agencies in South Asia are actively funding cancer research, which is expanding the market for companies providing mammalian cell banking services.

Barriers to Market Growth: Lack of Skilled Professionals

Despite the promising growth prospects, the Mammalian Cell Banking Market faces challenges, primarily due to a shortage of skilled professionals in research and development. The lack of skilled experts hampers innovation and the generation of new knowledge in the field. Factors such as low salary scales, challenging roles, and insufficient laboratory training contribute to this shortage. Specialized laboratory training courses are essential for handling cell line cultures, but the cost of these courses can deter individuals from pursuing careers in this field, thereby hindering market growth.

Booming U.S. Market

The United States is witnessing a significant boom in the Mammalian Cell Banking Market, driven by the expansion of cancer research. Key manufacturers are focusing on increasing staff productivity, enhancing flexibility, and improving efficiency. Service consolidation activities, including sales and service agreements, collaborations, research and development efforts, new service launches, and mergers & acquisitions by both global and regional players, are shaping the competitive landscape within the U.S. market.

Lucrative Opportunities in India

India presents lucrative opportunities in the Mammalian Cell Banking Market, owing to its growing cancer burden. With over 1 million new cases of cancer reported annually, this number is expected to rise due to demographic changes and lifestyle factors. The Department of Biotechnology (DBT) in India is providing resources for multi-institutional networking programs, individual investigators, and institutions through its Research & Development programs focused on cancer disease. This initiative is set to drive further growth in the Indian market.

Emerging Prominence in Japan

Japan is emerging as a prominent market for specialized cell culture services. The evolving needs of the research community have led to increased demand for customized solutions, as researchers prefer tailored approaches to meet the specific requirements of their projects. Vendors are responding by building robust distribution networks to rapidly deliver services from their manufacturing plants in the region. This emphasis on customization is propelling the growth of the Mammalian Cell Banking Market in Japan.

Competitive Landscape Analysis

Key players in the Mammalian Cell Banking Market are actively pursuing strategies such as product launches, strategic alliances, acquisitions, and facility expansions to strengthen their market presence. These efforts aim to enhance the development of new technologies and innovative research capabilities within the industry.

Key Companies Profiled
• Eurofins DiscoverX Corporation
• Merck KGaA
• Sartorius Stedim BioOutsource Limited
• Charles River Laboratories
• Altogen Labs
• Abzena Ltd
• Northway Biotechpharma
• Lonza Group Ltd
• VIRUSURE
• Selexis SA
• Takara Bio Inc

The Mammalian Cell Banking Market is poised for remarkable growth, driven by the imperative role it plays in advancing oncological research and supported by global initiatives. As the market continues to evolve, key players are positioning themselves to meet the increasing demand for specialized cell culture services.

Key Segments Covered in Manufacturing of Industry Research

Cell Type:
• CHO
• BHK
• NS0
• YB2/0 & P2/0
• HEK293 & Derivatives
• HELA

Technology:
• TEP
• IEP
• SEP

Application:
• MCB
• WCB
• EoP
• R&D CB

End User:
• Academic & Research Institute
• Biopharmaceutical Companies
• CROs

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East & Africa (MEA)

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.